Results of the NN104 study were covered in the San Diego Union-Tribune. The article details the development of 3K3A-APC, the study drug, originally developed by The Scripps Research Institute in La Jolla, CA.
NN104 RHAPSODY Coverage in the San Diego Union-Tribune
External Source: San Diego Union Tribune, February 21, 2018